Haploidentical donor NK cell therapy (University of Wisconsin)
半相合自然杀伤细胞（威斯康星大学）
Report date: 2024/01/02 20:03:52
Base Information
Drug NameHaploidentical donor NK cell therapy (University of Wisconsin)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-MadisonNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteUniversity Of Wisconsin-Madison
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A